Q1 2018 Holdings
Filed 2018-05-15 | 114 holdings | $2.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| BeiGene, Ltd.(ONC) | SPONSORED ADR | 07725L102 | $979.3M | 5,829,429 | 37.4% |
| BioMarin Pharmaceutical Inc.(BMRN) | COM | 09061G101 | $614.8M | 7,583,084 | 23.5% |
| Acadia Pharmaceuticals Inc.(ACAD) | COM | 004225108 | $611.8M | 27,228,338 | 23.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $185.6M | 2,837,352 | 7.1% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $77.4M | 961,754 | 3.0% |
| BioCryst Pharmaceuticals, Inc.(BCRX) | COM | 09058V103 | $66.8M | 14,012,172 | 2.6% |
| Cerus Corporation(CERS) | COM | 157085101 | $58.9M | 10,749,937 | 2.3% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | COM | 14888U101 | $10.5M | 4,381,072 | 0.4% |
| Incyte Corporation(INCY) | COM | 45337C102 | $2.9M | 34,230,751 | 0.1% |
| Seattle Genetics, Inc. | COM | 812578102 | $2.6M | 49,575,409 | 0.1% |
| Cellectis S.A.(CLLS) | SPONSORED ADS | 15117K103 | $1.6M | 50,000 | 0.1% |
| Adaptimmune Therapeutics plc(ADAPY) | SPONSORED ADR | 00653A107 | $1.1M | 100,000 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | COM | 015351109 | $953.6K | 8,555,894 | 0.0% |
| Arbutus Biopharma Corporation(ABUS) | COM | 03879J100 | $903.0K | 180,582 | 0.0% |
| Genomic Health, Inc.(GHDX) | COM | 37244C101 | $431.5K | 13,789,936 | 0.0% |
| Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | $154.0K | 10,934,154 | 0.0% |
| AveXis, Inc. | COM | 05366U100 | $144.2K | 1,167,157 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | COM | 427746102 | $138.7K | 5,025,298 | 0.0% |
| DBV Technologies S.A. | SPONSORED ADR | 23306J101 | $127.1K | 5,509,560 | 0.0% |
| Ablynx NV | SPONSORED ADR | 00372Y105 | $118.8K | 2,176,802 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | COM | 78667J108 | $104.2K | 646,828 | 0.0% |
| Array BioPharma Inc.(ARRYEUR) | COM | 04269X105 | $92.3K | 5,656,196 | 0.0% |
| Spark Therapeutics, Inc. | COM | 84652J103 | $92.2K | 1,384,130 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | COM | 64125C109 | $78.3K | 944,624 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | COM | 60468T105 | $78.3K | 2,549,461 | 0.0% |
| Madrigal Pharmaceuticals, Inc.(MDGL) | COM | 558868105 | $71.9K | 615,684 | 0.0% |
| Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | $71.1K | 38,641,462 | 0.0% |
| Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | $68.2K | 22,669,509 | 0.0% |
| Erytech Pharma S.A. | SPONSORED ADR | 29604W108 | $64.9K | 3,090,069 | 0.0% |
| Novavax, Inc. | Note 3.75% 2/1/2023 | 670002AB0 | $61.9K | $88,500,000 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | COM | 23257D103 | $50.9K | 3,917,700 | 0.0% |
| Rhythm Pharmaceuticals, Inc.(RYTM) | COM NEW | 76243J105 | $40.8K | 2,049,020 | 0.0% |
| Invitae Corporation(NVTA1EUR) | COM | 46185L103 | $39.4K | 8,399,411 | 0.0% |
| bluebird bio, Inc. | COM | 09609G100 | $34.2K | 200,000 | 0.0% |
| Abeona Therapeutics Inc.(ABEO1EUR) | COM | 00289Y107 | $31.3K | 2,184,364 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | COM | 40637H109 | $31.0K | 1,581,424 | 0.0% |
| Sangamo Therapeutics, Inc.(SGMO) | COM | 800677106 | $30.5K | 1,607,579 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $29.3K | 275,396 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | COM | 079481107 | $27.2K | 4,151,578 | 0.0% |
| Menlo Therapeutics Inc. | COM | 586858102 | $26.3K | 700,000 | 0.0% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $26.1K | 872,072 | 0.0% |
| Galapagos NV(GLPG) | SPONSORED ADR | 36315X101 | $25.9K | 259,894 | 0.0% |
| Exelixis, Inc.(EXEL) | COM | 30161Q104 | $25.8K | 1,162,644 | 0.0% |
| GW Pharmaceuticals plc | ADS | 36197T103 | $25.0K | 221,800 | 0.0% |
| Merus N.V. | COM | N5749R100 | $21.5K | 1,160,014 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $21.5K | 673,908 | 0.0% |
| Endocyte, Inc. | COM | 29269A102 | $20.7K | 2,277,799 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | COM | 45826J105 | $17.6K | 833,795 | 0.0% |
| Progenics Pharmaceuticals, Inc. | COM | 743187106 | $17.2K | 2,306,184 | 0.0% |
| Insmed Incorporated(INSM) | COM PAR $.01 | 457669307 | $15.8K | 700,000 | 0.0% |